Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Immunoglobulin G (IgG) mediates pro- and anti-inflammatory activities through the engagement of its Fc fragment (Fc) with distinct Fcg receptors (FcgRs). One class of Fc-FcgR interactions generates pro-inflammatory effects of immune complexes and cytotoxic antibodies. In contrast, therapeutic intravenous gamma globulin and its Fc fragments are anti-inflammatory. We show here that these distinct properties of the IgG Fc result from differential sialylation of the Fc core polysaccharide. IgG acquires anti-inflammatory properties upon Fc sialylation, which is reduced upon the induction of an antigen-specific immune response. This differential sialylation may provide a switch from innate anti-inflammatory activity in the steady state to generating adaptive pro-inflammatory effects upon antigenic challenge.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CREB activation can promote the expression of anti-inflammatory genes while inhibiting inflammatory genes.294,295”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [295]
Citations
Cites
Shields, R. L., Lai, J., Keck, R., O'Connell, L. Y., Hong, K., Meng, Y. G., Weikert, S. H. A., & Presta, L. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202069200 · Cited by 1,835
HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD
Imbach, P., d'APUZZO, V., Hirt, A., Rossi, E., Vest, M., Barandun, S., Baumgartner, C., Morell, A., Schöni, M., & Wagner, H. P. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92400-4 · Cited by 1,666
Parekh, R. B., Dwek, R. A., Sutton, B. J., Fernandes, D. L., Leung, A., Stanworth, D., Rademacher, T. W., Mizuochi, T., Taniguchi, T., Matsuta, K., et al. (1985) · Nature · doi:10.1038/316452a0 · Cited by 1,170
Fcγ Receptors: Old Friends and New Family Members
Nimmerjahn, F., & Ravetch, J. V. (2006) · Immunity · doi:10.1016/j.immuni.2005.11.010 · Cited by 1,072
Self-citationAnti-inflammatory Activity of IVIG Mediated Through the Inhibitory Fc Receptor
Samuelsson, A., Towers, T. L., & Ravetch, J. V. (2001) · Science · doi:10.1126/science.291.5503.484 · Cited by 1,053
Self-citationDivergent Immunoglobulin G Subclass Activity Through Selective Fc Receptor Binding
Nimmerjahn, F., & Ravetch, J. V. (2005) · Science · doi:10.1126/science.1118948 · Cited by 1,037
Self-citationArthritis Critically Dependent on Innate Immune System Players
Ji, H., Ohmura, K., Mahmood, U., Lee, D. M., Hofhuis, F. M. A., Boackle, S. A., Takahashi, K., Holers, V. M., Walport, M., Gerard, C., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00275-3 · Cited by 693
FcγRIV: A Novel FcR with Distinct IgG Subclass Specificity
Nimmerjahn, F., Bruhns, P., Horiuchi, K., & Ravetch, J. V. (2005) · Immunity · doi:10.1016/j.immuni.2005.05.010 · Cited by 660
Self-citationManipulating the Immune System with Immune Globulin
Oates, J. A., Wood, A. J. J., & Dwyer, J. M. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201093260206 · Cited by 648
Effect of glycosylation on antibody function: implications for genetic engineering
Wright, A., & Morrison, S. L. (1997) · Trends in Biotechnology · doi:10.1016/s0167-7799(96)10062-7 · Cited by 312
Research works printed but not linked: 1
- M. Holland et al., Biochim. Biophys. Acta1760, 669 (2005).
Cited by
Items 201–300 of 1,003
Engineering mammalian cells in bioprocessing – current achievements and future perspectives
Lim, Y., Wong, N. S. C., Lee, Y. Y., Ku, S. C. Y., Wong, D. C. F., & Yap, M. G. S. (2010) · Biotechnology and Applied Biochemistry · doi:10.1042/ba20090363 · Cited by 133
Multiple Mechanisms of Immune Suppression by B Lymphocytes
Klinker, M. W., & Lundy, S. K. (2012) · Molecular Medicine · doi:10.2119/molmed.2011.00333 · Cited by 132
Impact of Glycosylation on Effector Functions of Therapeutic IgG
Abès, R., & Teillaud, J. (2010) · Pharmaceuticals · doi:10.3390/ph3010146 · Cited by 156
Research and development of next generation of antibody-based therapeutics
Li, J., & Zhu, Z. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.120 · Cited by 132
Nandakumar, K. S., & Holmdahl, R. (2006) · Arthritis Research & Therapy · doi:10.1186/ar2089 · Cited by 154
Schwab, I., Mihai, S., Seeling, M., Kasperkiewicz, M., Ludwig, R. J., & Nimmerjahn, F. (2014) · European Journal of Immunology · doi:10.1002/eji.201344230 · Cited by 129
Self-citationA Mechanistic Perspective of Monoclonal Antibodies in Cancer Therapy Beyond Target-Related Effects
Strome, S. E., Sausville, E. A., & Mann, D. L. (2007) · The Oncologist · doi:10.1634/theoncologist.12-9-1084 · Cited by 147
An 'omics approach towards CHO cell engineering
Datta, P., Linhardt, R. J., & Sharfstein, S. T. (2013) · Biotechnology and Bioengineering · doi:10.1002/bit.24841 · Cited by 128
Kapur, R., Della Valle, L., Sonneveld, M., Hipgrave Ederveen, A., Visser, R., Ligthart, P., de Haas, M., Wuhrer, M., van der Schoot, C. E., & Vidarsson, G. (2014) · British Journal of Haematology · doi:10.1111/bjh.12965 · Cited by 128
Yu, X., Vasiljević, S., Mitchell, D. A., Crispin, M., & Scanlan, C. N. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.02.006 · Cited by 130
Selman, M. H. J., Derks, R. J. E., Bondt, A., Palmblad, M., Schoenmaker, B., Koeleman, C. A. M., van de Geijn, F. E., Dolhain, R. J. E. M., Deelder, A. M., & Wuhrer, M. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.11.003 · Cited by 140
Li, T., Tong, X., Yang, Q., Giddens, J. P., & Wang, L. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.738765 · Cited by 135
Estrogens regulate glycosylation of IgG in women and men
Ercan, A., Kohrt, W. M., Cui, J., Deane, K. D., Pezer, M., Yu, E. W.-Y., Hausmann, J. S., Campbell, H. J., Kaiser, U. B., Rudd, P. M., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.89703 · Cited by 142
Impact of structural modifications of IgG antibodies on effector functions
Damelang, T., Brinkhaus, M., van Osch, T. L. J., Schuurman, J., Labrijn, A. F., Rispens, T., & Vidarsson, G. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1304365 · Cited by 123
Regulation of B Cell Functions by the Sialic Acid-Binding Receptors Siglec-G and CD22
Jellusova, J., & Nitschke, L. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2011.00096 · Cited by 126
T cell–independent B cell activation induces immunosuppressive sialylated IgG antibodies
Hess, C., Winkler, A., Lorenz, A. K., Holecska, V., Blanchard, V., Eiglmeier, S., Schoen, A.-L., Bitterling, J., Stoehr, A. D., Petzold, D., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65938 · Cited by 126
Naturally occurring glycan forms of human immunoglobulins G1 and G2
Flynn, G. C., Chen, X., Liu, D., Shah, B., & Zhang, Z. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.04.006 · Cited by 135
Bieber, K., Hundt, J. E., Yu, X., Ehlers, M., Petersen, F., Karsten, C. M., Köhl, J., Kridin, K., Kalies, K., Kasprick, A., et al. (2022) · Autoimmunity Reviews · doi:10.1016/j.autrev.2022.103236 · Cited by 151
The regulatory power of glycans and their binding partners in immunity
Johnson, J. L., Jones, M. B., Ryan, S. O., & Cobb, B. A. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.01.006 · Cited by 125
IgG and Fcγ Receptors in Intestinal Immunity and Inflammation
Castro‐Dopico, T., & Clatworthy, M. R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00805 · Cited by 139
Käsermann, F., Boerema, D. J., Rüegsegger, M., Hofmann, A., Wymann, S., Zuercher, A. W., & Miescher, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037243 · Cited by 124
Evaluating the impact of cell culture process parameters on monoclonal antibody N-glycosylation
Ivarsson, M., Villiger, T. K., Morbidelli, M., & Šoóš, M. (2014) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2014.08.026 · Cited by 148
Antibody engineering and modification technologies
Filpula, D. R. (2007) · Biomolecular Engineering · doi:10.1016/j.bioeng.2007.03.004 · Cited by 153
Mehta, A. S., Long, R. E., Comunale, M. A., Wang, M., Rodemich-Betesh, L., Krakover, J. D., Philip, R., Marrero, J. A., Dwek, R. A., & Block, T. M. (2007) · Journal of Virology · doi:10.1128/jvi.01600-07 · Cited by 137
Hinge-Region O-Glycosylation of Human Immunoglobulin G3 (IgG3)
Plomp, R., Dekkers, G., Rombouts, Y., Visser, R., Koeleman, C. A. M., Lageveen‐Kammeijer, G. S. M., Jansen, B. C., Rispens, T., Hensbergen, P. J., Vidarsson, G., et al. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.047381 · Cited by 137
Zhang, X., Teng, Y., Fu, Y., Xu, L., Zhang, S., He, B., Wang, C., & Zhang, W. (2010) · Analytical Chemistry · doi:10.1021/ac102132p · Cited by 123
Vicente-Perez, E. M., Larrañeta, E., McCrudden, M., Kissenpfennig, A., Hegarty, S. M., McCarthy, H. O., & Donnelly, R. F. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.04.029 · Cited by 125
IgG glycan patterns are associated with type 2 diabetes in independent European populations
Lemmers, R. F. H., Vilaj, M. Ć., Urda, D., Agakov, F. V., Šimurina, M., Klarić, L., Rudan, I., Campbell, H. J., Hayward, C., Wilson, J., et al. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2017.06.020 · Cited by 135
Regulated Glycosylation Patterns of IgG during Alloimmune Responses against Human Platelet Antigens
Wuhrer, M., Porcelijn, L., Kapur, R., Koeleman, C. A. M., Deelder, A. M., de Haas, M., & Vidarsson, G. (2009) · Journal of Proteome Research · doi:10.1021/pr800651j · Cited by 119
Antibody Glycosylation and Inflammation
Shade, K.-T., & Anthony, R. M. (2013) · Antibodies · doi:10.3390/antib2030392 · Cited by 143
Leontyev, D., Katsman, Y., Ma, X., Miescher, S., Käsermann, F., & Branch, D. R. (2012) · Transfusion · doi:10.1111/j.1537-2995.2011.03517.x · Cited by 119
Liu, B., Spearman, M. A., Doering, J., Lattová, E., Perreault, H., & Butler, M. (2013) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2013.11.007 · Cited by 141
Physiochemical and Biochemical Factors Influencing the Pharmacokinetics of Antibody Therapeutics
Bumbaca, D., Boswell, C. A., Fielder, P. J., & Khawli, L. A. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9369-y · Cited by 119
Rongqing, Z., Li, M., Song, H., Chen, J., Ren, W., Feng, Y., Gao, G. F., Song, J., Peng, Y., Su, B., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa523 · Cited by 133
N-Glycosylation of Plant-produced Recombinant Proteins
Bosch, D., Castilho, A., Loos, A., Schots, A., & Steinkellner, H. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319310006 · Cited by 121
NMR Characterization of Immunoglobulin G Fc Glycan Motion on Enzymatic Sialylation
Barb, A. W., Meng, L., Gao, Z., Johnson, R. W., Moremen, K. W., & Prestegard, J. H. (2012) · Biochemistry · doi:10.1021/bi300319q · Cited by 117
Absolute Quantitation of Immunoglobulin G and Its Glycoforms Using Multiple Reaction Monitoring
Hong, Q., Lebrilla, C. B., Miyamoto, S., & Ruhaak, L. R. (2013) · Analytical Chemistry · doi:10.1021/ac4009995 · Cited by 116
Role of siglecs and related glycan-binding proteins in immune responses and immunoregulation
Bochner, B. S., & Zimmermann, N. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.11.031 · Cited by 113
Blum, M. A., Wigley, F. M., & Hummers, L. K. (2008) · Medicine · doi:10.1097/md.0b013e3181630835 · Cited by 116
Wang, X., Xia, N., & Liu, L. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141020890 · Cited by 115
The sweet tooth of biopharmaceuticals: Importance of recombinant protein glycosylation analysis
Lingg, N., Zhang, P., Song, Z., & Bardor, M. (2012) · Biotechnology Journal · doi:10.1002/biot.201200078 · Cited by 114
The B cell response to citrullinated antigens in the development of rheumatoid arthritis
Scherer, H. U., Huizinga, T. W. J., Krönke, G., Schett, G. A., & Toes, R. E. M. (2018) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2018.10 · Cited by 125
Intravenous Immunoglobulin a Natural Regulator of Immunity and Inflammation
Jordan, S. C., Toyoda, M., & Vo, A. A. (2009) · Transplantation · doi:10.1097/tp.0b013e3181a9e89a · Cited by 118
Nandakumar, K. S., Collin, M., Olsén, A., Nimmerjahn, F., Blom, A. M., Ravetch, J. V., & Holmdahl, R. (2007) · European Journal of Immunology · doi:10.1002/eji.200737581 · Cited by 118
Self-citationMimura, Y., Ashton, P. R., Takahashi, N., Harvey, D. J., & Jefferis, R. (2007) · Journal of Immunological Methods · doi:10.1016/j.jim.2007.07.014 · Cited by 114
Guhr, T., Bloem, J., Derksen, N. I. L., Wuhrer, M., Koenderman, A. H. L., Aalberse, R. C., & Rispens, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021246 · Cited by 113
Puzzling inefficiency of H5N1 influenza vaccines in Egyptian poultry
Kim, J.-K., Kayali, G., Walker, D., Forrest, H. L., Ellebedy, A. H., Griffin, Y., Rubrum, A. M., Bahgat, M. M., Kutkat, M. A. A., Ali, M. A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006419107 · Cited by 113
Diversification of IgG effector functions
Bournazos, S., & Ravetch, J. V. (2017) · International Immunology · doi:10.1093/intimm/dxx025 · Cited by 112
Self-citationA method to identify trace sulfated IgG N-glycans as biomarkers for rheumatoid arthritis
Wang, J., Gao, W., Grimm, R., Jiang, S., Liang, Y. Q., Ye, H., Li, Z., Yau, L., Huang, H., Liu, J., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00662-w · Cited by 125
Nagelkerke, S. Q., Dekkers, G., Kustiawan, I., van de Bovenkamp, F. S., Geissler, J., Plomp, R., Wuhrer, M., Vidarsson, G., Rispens, T., van den Berg, T. K., et al. (2014) · Blood · doi:10.1182/blood-2014-05-576835 · Cited by 114
Glycomics, glycoproteomics and the immune system
Kolarich, D., Lepenies, B., & Seeberger, P. H. (2012) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2011.12.006 · Cited by 127
Fiebiger, B. M., Maamary, J., Pincetic, A., & Ravetch, J. V. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505292112 · Cited by 111
Self-citationTang, F., Yang, Y., Tang, Y., Tang, S., Yang, L., Sun, B., Jiang, B., Dong, J., Liu, H., Huang, M., et al. (2016) · Organic & Biomolecular Chemistry · doi:10.1039/c6ob01751g · Cited by 114
IgG glycan hydrolysis by a bacterial enzyme as a therapy against autoimmune conditions
Collin, M., Shannon, O., & Björck, L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711271105 · Cited by 112
Hoshino, A., Nagao, T., Nagi‐Miura, N., Ohno, N., Yasuhara, M., Yamamoto, K., Nakayama, T., & Suzuki, K. T. (2008) · Journal of Autoimmunity · doi:10.1016/j.jaut.2008.03.006 · Cited by 117
Selman, M. H. J., McDonnell, L. A., Palmblad, M., Ruhaak, L. R., Deelder, A. M., & Wuhrer, M. (2010) · Analytical Chemistry · doi:10.1021/ac9024413 · Cited by 111
Tang, F., Wang, L., & Huang, W. (2017) · Nature Protocols · doi:10.1038/nprot.2017.058 · Cited by 113
Novel Concepts of Altered Immunoglobulin G Galactosylation in Autoimmune Diseases
Dekkers, G., Rispens, T., & Vidarsson, G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00553 · Cited by 123
Wu, C., Yang, H., & Lai, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114015 · Cited by 137
Glycosylation and Fc Receptors
Hayes, J. M., Cosgrave, E. F. J., Struwe, W. B., Wormald, M., Davey, G. P., Jefferis, R., & Rudd, P. M. (2014) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-319-07911-0_8 · Cited by 110
IVI g‐mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR 1
Schwab, I., Biburger, M., Krönke, G., Schett, G., & Nimmerjahn, F. (2012) · European Journal of Immunology · doi:10.1002/eji.201142260 · Cited by 110
Self-citationToward the Treatment and Prevention of Alzheimer's Disease: Rational Strategies and Recent Progress
Gandy, S., & DeKosky, S. T. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-092611-084441 · Cited by 110
“The “active ingredient” in IVIG has been proposed to be naturally occurring anti-Aβ oligomer antibodies (69), although other potentially active IVIG ingredients are also receiving attention (70).”
BackgroundTechnological progresses in monoclonal antibody production systems
Rodrigues, M. E., Costa, A. R., Henriques, M., Azeredo, J., & Oliveira, R. (2009) · Biotechnology Progress · doi:10.1002/btpr.348 · Cited by 142
Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid
Wuhrer, M., Selman, M. H. J., McDonnell, L. A., Kümpfel, T., Derfuss, T. J., Khademi, M., Olsson, T. P., Hohlfeld, R., Meinl, E., & Krumbholz, M. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0450-1 · Cited by 131
Mechanisms of action of intravenous immunoglobulin
Chaigne, B., & Mouthon, L. (2016) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2016.12.017 · Cited by 110
Intravenous Immunoglobulins as a Treatment for Alzheimerʼs Disease: Rationale and Current Evidence
Dodel, R. C., Neff, F., Noelker, C., Pul, R., Du, Y., Bacher, M., & Oertel, W. H. (2010) · Drugs · doi:10.2165/11533070-000000000-00000 · Cited by 125
A close look at human IgG sialylation and subclass distribution after lectin fractionation
Stadlmann, J., Weber, A., Pabst, M., Anderle, H., Kunert, R., J. Ehrlich, H., Peter Schwarz, H., & Altmann, F. (2009) · PROTEOMICS · doi:10.1002/pmic.200800931 · Cited by 109
Kodar, K., Stadlmann, J., Klaamas, K., Sergeyev, B., & Kurtenkov, O. A. (2011) · Glycoconjugate Journal · doi:10.1007/s10719-011-9364-z · Cited by 119
Impact of autoantibody glycosylation in autoimmune diseases
Goulabchand, R., Vincent, T., Batteux, F., Eliaou, J., & Guilpain, P. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.02.005 · Cited by 120
Wang, Y., Klarić, L., Yu, X., Thaqi, K., Dong, J., Novokmet, M., Wilson, J., Polašek, O., Liu, Y., Krištić, J., et al. (2016) · Medicine · doi:10.1097/md.0000000000003379 · Cited by 119
Tanigaki, K., Sacharidou, A., Peng, J., Chambliss, K. L., Yuhanna, I. S., Ghosh, D., Ahmed, M., Szalai, A. J., Vongpatanasin, W., Mattrey, R. F., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci89333 · Cited by 107
Neuroimmunological therapies for treating spinal cord injury: Evidence and future perspectives
Chio, J. C. T., Xu, K. J., Popovich, P. G., David, S., & Fehlings, M. G. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113704 · Cited by 111
Tolerance induction with T cell–dependent protein antigens induces regulatory sialylated IgGs
Oefner, C. M., Winkler, A., Heß, C., Lorenz, A. K., Holecska, V., Huxdorf, M., Schommartz, T., Petzold, D., Bitterling, J., Schoen, A.-L., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.02.037 · Cited by 120
Baudino, L., Shinohara, Y., Nimmerjahn, F., Furukawa, J.-I., Nakata, M., Martínez-Soria, E., Petry, F., Ravetch, J. V., Nishimura, S.-I., & Izui, S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.6664 · Cited by 107
Self-citationProduction of α2,6-sialylated IgG1 in CHO cells
Raymond, C., Robotham, A., Spearman, M., Butler, M., Kelly, J., & Durocher, Y. (2015) · mAbs · doi:10.1080/19420862.2015.1029215 · Cited by 106
Tanaka, K., Siwu, E. R. O., Minami, K., Hasegawa, K., Nozaki, S., Kanayama, Y., Koyama, K., Chen, W. C., Paulson, J. C., Watanabe, Y., et al. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201000892 · Cited by 106
Inflammatory etiopathogenesis of systemic lupus erythematosus: an update
i, M. H., Podolska, M. J., Biermann, M. H. C., Maueröder, C., & Hahn, J. (2015) · Journal of Inflammation Research · doi:10.2147/jir.s70325 · Cited by 126
Kobata, A. (2007) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2007.06.012 · Cited by 108
Transient expression and purification of chimeric heavy chain antibodies
Zhang, J., Liu, X., Bell, A., To, R., Baral, T. N., Azizi, A., Li, J., Cass, B., & Durocher, Y. (2008) · Protein Expression and Purification · doi:10.1016/j.pep.2008.10.011 · Cited by 110
Intravenous immunoglobulin as clinical immune-modulating therapy
Gilardin, L., Bayry, J., & Kaveri, S. V. (2015) · Canadian Medical Association Journal · doi:10.1503/cmaj.130375 · Cited by 103
The multiple facets of FcRn in immunity
Stapleton, N. M., Einarsdóttir, H. K., Stemerding, A. M., & Vidarsson, G. (2015) · Immunological Reviews · doi:10.1111/imr.12331 · Cited by 103
Lilienthal, G., Rahmöller, J., Petry, J., Bartsch, Y. C., Leliavski, A., & Ehlers, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00958 · Cited by 115
Site-selective chemoenzymatic glycoengineering of Fab and Fc glycans of a therapeutic antibody
Giddens, J. P., Lomino, J. V., DiLillo, D. J., Ravetch, J. V., & Wang, L. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1812833115 · Cited by 108
Self-citationNatural Antibodies: from First-Line Defense Against Pathogens to Perpetual Immune Homeostasis
Maddur, M. S., Lacroix‐Desmazes, S., Dimitrov, J. D., Kazatchkine, M. D., Bayry, J., & Kaveri, S. V. (2019) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-019-08746-9 · Cited by 113
Sonneveld, M. E., Natunen, S., Sainio, S., Koeleman, C. A. M., Holst, S., Dekkers, G., Koelewijn, J. M., Partanen, J., van der Schoot, C. E., Wuhrer, M., et al. (2016) · British Journal of Haematology · doi:10.1111/bjh.14053 · Cited by 115
Multi-angle effector function analysis of human monoclonal IgG glycovariants
Dashivets, T., Thomann, M., Rueger, P., Knaupp, A., Buchner, J., & Schlothauer, T. (2015) · PLOS ONE · doi:10.1371/journal.pone.0143520 · Cited by 101
“[85] Sialylated antibodies are believed to be the pro-active species in IVIG (Intravenous Immune Globulin), which suppresses autoantibodymediated inflammation by activating the inhibitory FcγRIIb and downstream negative signaling pathways.”
BackgroundPutnam, W. S., Prabhu, S., Zheng, Y., Subramanyam, M., & Wang, Y. (2010) · Trends in biotechnology · doi:10.1016/j.tibtech.2010.07.001 · Cited by 108
Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts
Baum, R., & Gravallese, E. M. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8515-6 · Cited by 101
Human IgG/FcγR Interactions Are Modulated by Streptococcal IgG Glycan Hydrolysis
Allhorn, M., Olin, A. I., Nimmerjahn, F., & Collin, M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001413 · Cited by 101
Self-citationChang, J., Shi, P. A., Chiang, E. Y., & Frenette, P. S. (2008) · Blood · doi:10.1182/blood-2007-04-084061 · Cited by 101
Regulation of antibody effector functions through IgG Fc N-glycosylation
Quast, I., Peschke, B., & Lünemann, J. D. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2366-z · Cited by 115
Impact of cell culture media additives on IgG glycosylation produced in Chinese hamster ovary cells
Ehret, J., Zimmermann, M., Eichhorn, T., & Zimmer, A. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.26904 · Cited by 111
Genetic glycoengineering in mammalian cells
Narimatsu, Y., Büll, C., Chen, Y., Wandall, H. H., Yang, Z., & Clausen, H. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100448 · Cited by 107
Glyco‐engineering in plants to produce human‐like N‐glycan structures
Castilho, A., & Steinkellner, H. (2012) · Biotechnology Journal · doi:10.1002/biot.201200032 · Cited by 105
Efficacy of Intravenous Immunoglobulin in Neurological Diseases
Lünemann, J. D., Quast, I., & Dalakas, M. C. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0391-5 · Cited by 112
How Autoantibodies Regulate Osteoclast Induced Bone Loss in Rheumatoid Arthritis
Steffen, U., Schett, G. A., & Bözec, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01483 · Cited by 111
Nimmerjahn, F., Vidarsson, G., & Cragg, M. S. (2023) · Nature Immunology · doi:10.1038/s41590-023-01544-8 · Cited by 110
Self-citationIdentification of N-Glycosylation Changes in the CSF and Serum in Patients with Schizophrenia
Stanta, J. L., Saldova, R., Struwe, W. B., Byrne, J. C., Leweke, F. M., Rothermund, M., Rahmoune, H., Levin, Y., Guest, P. C., Bahn, S., et al. (2010) · Journal of Proteome Research · doi:10.1021/pr1002356 · Cited by 106
Analytical comparability study of recombinant monoclonal antibody therapeutics
Ambrogelly, A., Gozo, S., Katiyar, A., Dellatore, S. M., Kune, Y., Bhat, R., Sun, J., Li, N., Wang, D., Nowak, C., et al. (2018) · mAbs · doi:10.1080/19420862.2018.1438797 · Cited by 106
Harvey, D. J. (2010) · Mass Spectrometry Reviews · doi:10.1002/mas.20265 · Cited by 105
Metadata
- Authors
- Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V.
- Affiliations
- Rockefeller University (US)
- Corresponding author
- Kaneko, Yoshikatsu
- Nimmerjahn, Falk
- Ravetch, Jeffrey V.
- Venue
- Science
- Published
- 2006-08-04
- Volume
- 313
- Issue
- 5787
- Pages
- 670-673
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2035433348
- Cited by
- 1,754
- References
- 21
- Citations by year
- 2026: 45 · 2025: 55 · 2024: 63 · 2023: 67 · 2022: 77 · 2021: 101 · 2020: 103 · 2019: 93 · 2018: 97 · 2017: 89 · 2016: 96 · 2015: 105 · 2014: 122 · 2013: 113 · 2012: 98
- FWCI
- 71.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- IgG, Fc fragment, anti-inflammatory activity, Fc gamma receptor, immune complexes, intravenous immunoglobulin, antigen-specific immune response, innate immunity, adaptive immunity, pro-inflammatory effects
- MeSH terms
- Animals, Antibodies, Monoclonal, Arthritis, Arthritis, Rheumatoid, Glycosylation, Half-Life, Immunoglobulin G, Immunoglobulin Fc Fragments, Inflammation, Mice, Inbred C57BL, Nephritis, Polysaccharides, Receptors, Fc, Sialic Acids, Mice, Inbred NOD, Immunoglobulins, Intravenous, Receptors, IgG, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.